Fifty two million children lived with viral hepatitis worldwide in 2016, while 2.1 million suffered from HIV/AIDS, a new study has revealed.
In 2016, an estimated 325 million people were living with viral hepatitis worldwide.
Of these, four million were children living with hepatitis C (under 19 years) and 48 million (under 18 years) were children living with hepatitis B. Both viruses can lead to liver disease, liver cancer and death, the findings presented at the 2017 World Hepatitis Summit in Brazil, showed.
“Children are suffering a huge burden of viral hepatitis worldwide and the public health implications of this are enormous,” said Raquel Peck, CEO of the World Hepatitis Alliance — London-based not-for-profit.
Twenty one countries are responsible for around 80 per cent of these pediatric hepatitis C infections, with the highest prevalence rates generally found in developing countries, noted Manal El-Sayed, professor in Egypt’s Shams University.
The main causes of hepatitis C in children is mother to child transmission. However, neither pregnant women nor young children with this cancer-causing illness can be treated with the highly effective direct-acting antiviral (DAA) medications, as health experts are yet to recommend the vaccine in children.
Further, the study showed that compared to hepatitis C, new hepatitis B infections among children are declining — from approximately 4.7 per cent prevalence in the pre-vaccination era of the early 1980s to 1.3 per cent.
This is due to scaled-up efforts to prevent mother-to-child transmission and global coverage with the three doses of hepatitis B vaccine.
Currently, 84 per cent of countries offer hepatitis B vaccinations. However, coverage with the initial birth dose vaccination needed to provide protection to newborns is still low at 39 per cent, the researchers added.
IANS